Journal of the European Academy of Dermatology and Venereology

Androgenic disorders
pp. 1-1(1)
Author: McKenna T.J.

Recent advances in psoriasis
pp. 1-1(1)
Author: Christophers E.

Recent advances in the understanding of melanogenesis and melanin pigmentary disorders
pp. 1-1(1)
Author: Ortonne J.-P.

Wound healing
pp. 1-2(2)
Author: Ferguson M.W.J.

Advances in the immunobiology of the skin
pp. 2-2(1)
Author: Katz S.I.

HIV in the year 2000
pp. 2-2(1)
Author: Katlama C.

Urticaria and autoimmunity
pp. 2-2(1)
Authors: Greaves M.W.; Sabroe R.

Genital ulcer disease 1997
pp. 2-3(2)
Author: Rosen T.

Early detection of malignant melanoma
pp. 3-3(1)
Author: Marks R.

Immunology update: Phototherapy
pp. 3-3(1)
Author: Bos J.D.

Quality and dermatology
pp. 5-5(1)
Author: Jemec G.B.E.

The changing prevalence of skin disease
pp. 5-5(1)
Author: Williams H.C.

Oncogene and tumor supressor genes in dermatology
pp. 5-5(1)
Author: Basset-Seguin N.

Drug interactions in dermatology
pp. 5-6(2)
Author: Puig i Sanz L.

Chronic inflammatory skin diseases
pp. 6-6(1)
Authors: Girolomoni G.; Pastore S.; Cavani A.

General strategy for psoriasis treatment
pp. 6-6(1)
Author: Dubertret L.

How to manage side-effects for longterm systemic treatments of psorias
pp. 6-6(1)
Author: Rogers S.

Clinical aspects of psoriasis; Combination treatments for psoriasis
pp. 6-6(1)
Author: van de Kerkhof P.C.M.

New therapeutic approaches for psoriasis
pp. 6-6(1)
Author: Luger T.A.

Quality of life with psoriasis
pp. 6-7(2)
Author: Finlay A.Y.

Psoriasis in children. A follow-up of 245 children under the age of 16 with psoriasis
pp. 7-7(1)
Author: Nyfors A.

Pemphigus: From bedside to molecule
pp. 7-7(1)
Author: Hashimoto T.

Gluten-free diet in dermatitis herpetiformis: With or without oats?
pp. 7-7(1)
Authors: Reunala T.; Collin P.; Maki M.

What the mouth tells us in bullous disease
pp. 7-8(2)
Author: McCartan B.E.

Autoantigens in cicatricial pemphigoid
pp. 8-8(1)
Author: Kirtschig G.

Making the diagnosis in bullous disease: Balancing the clinician and tests
pp. 8-8(1)
Authors: Wojnarowska F.; Allen J.

Epidermolysis bullosa - An update
pp. 8-8(1)
Author: Heagerty A.H.M.

Controversies in dermatological lasers
pp. 9-9(1)
Author: Allen G.E.

Strawberry nevi - To treat or not to treat?
pp. 9-9(1)
Authors: Landthaler M.; Hohenleutner U.

Why do some port wine stains not respond to the pulsed dye laser?
pp. 9-9(1)
Author: Lanigan S.W.

What age should treatment for vascular naevi be started? Are we treating the patient or the parent?
pp. 9-9(1)
Author: Walker N.P.J.

Laser treatment of benign pigmented lesions
pp. 9-10(2)
Author: Lowe N.J.

Skin resurfacing
pp. 10-10(1)
Author: Trelles M.A.

Hair removal
pp. 10-10(1)
Author: Cotterill J.A.

Genital Candida and anaerobes
pp. 10-10(1)
Author: Bingham J.S.

Recurrent vulvovaginal candidiasis (RVVC)
pp. 10-10(1)
Author: Sobel J.D.

Biology of Candida in the vaginal Candida context
pp. 10-11(2)
Author: Odds F.C.

The application of molecular tools to the analysis of populations of Candida species
pp. 11-11(1)
Authors: Coleman D.C.; Sullivan D.; Shanley D.

Candida dubliniensis; A new species of Candida which is pathogenic in humans
pp. 11-11(1)
Authors: Sullivan D.J.; Coleman D.C.; Shanley D.

Bacterial vaginosis - Pathogenesis and the importance
pp. 11-12(2)
Author: Taylor-Robinson D.

Bacterial vaginosis: A review of etiological factors and effects on fertility
pp. 12-12(1)
Author: McCaffrey M.

The biological effects of the peeling
pp. 12-12(1)
Author: Dasiou-Plakida D.

How to select the best peel for the right patient
pp. 12-12(1)
Author: Robins P.

Peeling-patient selection and prevention of adverse reactions
pp. 12-12(1)
Author: Katsambas A.D.

Glycolic acid peel
pp. 12-13(2)
Author: Rusciani L.

The place of T.C.A. in chemical peel
pp. 13-13(1)
Author: Camps-Fresneda A.

The TCA Mask
pp. 13-13(1)
Author: Letessier S.

Chemical peels with CO₂ laser and dermabrasion
pp. 13-13(1)
Author: Roenigk H.H.

The epidemiology of melanoma in Scotland 1978-1994
pp. 13-13(1)
Authors: MacKie R.M.; Hole D.J.; Soutar D.; Hunter J.; Rankin R.; Evans A.; McLaren K.

Epidemiology of cutaneous melanoma in Germany
pp. 13-13(1)
Author: Garbe C.

Current advances in melanoma in Italy at the present time
pp. 14-14(1)
Author: Giannotti B.

An update on melanoma in Dublin
pp. 14-14(1)
Author: Barnes L.

The Australian experience and conclusions
pp. 14-14(1)
Author: Marks R.

The clinical spectrum of cutaneous lupus erythematosus
pp. 14-15(2)
Author: Watson R.

Ultraviolet light and pathomechanisms of photosensitive Lupus
pp. 15-15(1)
Authors: Kind P.; Germaier H.; Walchner M.

Rationale for treatment of cutaneous lupus
pp. 15-15(1)
Author: Norris D.A.

Management of life-threatening systemic lupus erythematosus
pp. 15-15(1)
Author: Hanly J.G.

Genetic aspects of atopic dermatitis
pp. 15-16(2)
Authors: Vabres P.; de Prost Y.

Environmental factors and atopic dermatitis - And why has the disease increased in incidence?
pp. 16-16(1)
Author: Thestrup-Pedersen K.

Disease mechanisms: What role does allergy play?
pp. 16-16(1)
Author: Stingl G.

Should we use immunosuppressive therapy in atopic dermatitis?
pp. 16-16(1)
Author: de Prost Y.

What are environmental dermatoses?
pp. 16-16(1)
Author: Diepgen T.L.

Occupational dermatoses-environmental dermatoses
pp. 16-17(2)
Author: Kanerva L.

Atopic dermatitis - An environmental disease based on data from patch testing
pp. 17-17(1)
Author: Turjanmaa K.

Environmental dry skin. From xerosis to eczema
pp. 17-17(1)
Author: Goncalo M.

The ozone depletion and the skin
pp. 17-17(1)
Author: Ortonne J.-P.

The epidemiology of bacterial infections
pp. 18-18(1)
Author: Krafchik B.R.

Spirochaetes and paediatric dermatology
pp. 18-18(1)
Author: Oranje A.P.

Superantigens and paediatric skin diseases
pp. 18-18(1)
Authors: Becherel P.A.; Frances C.; Chosidow O.

Viral and drugs exanthems: An update
pp. 18-18(1)
Authors: Gelmetti C.; Speich S.; Coggi A.

Significance of HPV infection of the genitalia in children
pp. 19-19(1)
Author: Handley J.

Toxic epidermal necrolysis
pp. 19-19(1)
Author: Revuz J.

Pemphigus
pp. 19-19(1)
Author: Anhalt G.J.

Life threatening skin infections
pp. 19-19(1)
Author: Hay R.J.

Paediatric dermatology: What we have to know and/or to treat in an emergency
pp. 19-19(1)
Authors: Hamel-Teillac D.; de Prost Y.

The changing pattern of clinic syphilis
pp. 19-20(2)
Author: Harris J.R.W.

Clinical syphilis - Modern management
pp. 20-20(1)
Author: Thin R.N.

Genital ulceration and HIV infection in Africa
pp. 20-20(1)
Author: Mabey D.

Differential diagnosis of genital ulcer disease
pp. 20-20(1)
Author: Rosen T.

Cancer and pre-cancer of the genitalia
pp. 20-20(1)
Author: Thornhill J.A.

Syphilis 1990's - The Russian experience
pp. 20-21(2)
Author: Gomberg M.A.

EORTC classification of primary cutaneous lymphoma
pp. 21-21(1)
Authors: van Vloten W.A.; Willemze R.

Mycosis fungoides: From clinical aspects to molecular biology
pp. 21-21(1)
Authors: Chimenti S.; Peris K.

Lymphomatoid papulosis: Management and treatment
pp. 21-21(1)
Authors: Souteyrand P.; D'Incan M.

Therapeutic approaches in cutaneous T cell lymphoma
pp. 21-22(2)
Author: Whittaker S.

Evaluation of patients with porphyria
pp. 22-22(1)
Author: Murphy G.M.

Update on enzyme and molecular defects in porphyria
pp. 22-22(1)
Author: Elder G.H.

Molecular genetics of erythropoietic protoporphyria
pp. 22-22(1)
Author: Todd D.J.

Human immunodeficiency virus (HIV), hepatitis C virus (HCV), and porphyria cutanea tarda (PCT)
pp. 22-22(1)
Author: Lim H.W.

Management of patients with porphyria cutanea tarda
pp. 22-23(2)
Authors: Herrero C.; Lecha M.

Hepatic complications of protoporphyria
pp. 23-23(1)
Authors: Doss M.O.; Freesemann A.G.; Frank M.; Grosz U.

Management of erythropoietic porphyrias
pp. 23-23(1)
Author: Mascaro J.M.

Management of the acute porphyrias
pp. 23-23(1)
Author: Kauppinen R.

The editorial process
pp. 23-23(1)
Author: Dinsmore W.W.

How to win friends and influence statistical referees!
pp. 24-24(1)
Author: Kelly A.

Memorable mistakes
pp. 24-24(1)
Author: Leite L.

Problems for nonenglish speaking author publishing in English
pp. 24-24(1)
Author: Onder M.

Keeping your reader interested
pp. 24-24(1)
Author: Parish L.C.

Publishing a scientific paper: The value of scientific literature today
pp. 24-24(1)
Author: Lotti T.M.

Tinea capitis - An emerging problem in Europe?
pp. 24-24(1)
Author: Hay R.J.

Etiopathogenic problems in onychomycoses
pp. 25-25(1)
Author: Haneke E.

The pharmacokinetics and penetration of antifungal drugs
pp. 25-25(1)
Author: Faergemann J.

Drug resistance and its clinical relevance
pp. 25-25(1)
Author: Warnock D.W.

Overview for symposium on epidermolysis bullosa
pp. 25-25(1)
Author: Eady R.A.J.

Keratin gene mutations and epidermolysis bullosa
pp. 25-26(2)
Author: McKenna K.E.

Recent advances in junctional epidermolysis bullosa
pp. 26-26(1)
Author: McGrath J.A.

The organization of a multidisciplinary Epidermolysis Bullosa clinic
pp. 26-26(1)
Author: Blanchet-Bardon C.

Nutritional requirements in epidermolysis bullosa (EB) patients
pp. 26-26(1)
Author: Haynes L.

Prenatal diagnosis of epidermolysis bullosa
pp. 26-26(1)
Author: Eady R.A.J.

The future of gene therapy for EB
pp. 26-27(2)
Author: McLean W.H.I.

Psoriasis genetics
pp. 27-27(1)
Author: Barker J.N.W.N.

Keratinocyte stem cell regulation in psoriasis
pp. 27-27(1)
Author: Leigh I.M.

Immunological cells in psoriasis pathogenesis
pp. 27-27(1)
Author: Baadsgaard O.

What therapeutic tools tell us about psoriasis pathogenesis
pp. 27-27(1)
Author: Dubertret L.

The importance of mycoplasmas as a cause of NGU
pp. 28-28(1)
Authors: Horner P.J.; Thomas B.J.; Gilroy C.; Renton A.; Taylor-Robinson D.

Immune response of the genital tract to Chlamydia trachomatis
pp. 28-28(1)
Author: Mazzoli S.

Diagnosis of urethritis by non-invasive sampling
pp. 28-29(2)
Author: Stary A.

Persistent urethritis: What to do?
pp. 29-29(1)
Author: Kohl P.K.

Can you correctly treat your acne patients?
pp. 29-29(1)
Author: Gollnick H.

Are new topical therapies better?
pp. 29-29(1)
Author: Leyden J.J.

Roaccutane 1997 - Do your patients fully benefit?
pp. 29-29(1)
Author: Cunliffe W.J.

Hidradenitis suppurativa - New ideas
pp. 29-29(1)
Author: Jemec G.B.E.

Nonsense acne therapy
pp. 30-30(1)
Author: Katsambas A.D.

Clinical, surgical and therapeutic pearls
pp. 30-30(1)
Author: Abimelec P.

Evaluation of the role of genital HPV in pathogenesis of ungual epidermoid carcinoma
pp. 30-30(1)
Authors: Andre J.; Noel J.-C.

The different faces of the pili bifurcati
pp. 30-31(2)
Author: Camacho F.M.

The pathological dynamics of androgenetic alopecia and its treatment
pp. 31-31(1)
Author: Dawber R.P.R.

Variants of myxoid cysts: Diagnosis and treatment
pp. 31-31(1)
Author: de Berker D.A.R.

Topical treatment of androgenetic alopecia with spironolactone
pp. 31-31(1)
Authors: Dill-Muller D.; Zaun H.

Toenail dystrophies and podiatric care: When and how?
pp. 31-31(1)
Author: Richert B.

Regulation of hair growth
pp. 31-32(2)
Author: Wollina U.

Fusarium onychomycosis
pp. 32-32(1)
Authors: Piraccini B.M.; Stinchi C.; Ghetti E.; Tosti A.

Human T cell leukaemia viruses: Origins, epidemiology and clinical significance
pp. 32-32(1)
Author: Hall W.W.

A vaccine for HIV?
pp. 32-32(1)
Authors: Gotch F.; McAdam S.; Whitworth J.

Immune evasion by the human immunodeficiency virus
pp. 32-32(1)
Author: Philips R.E.

Dithranol, still going strong
pp. 33-33(1)
Author: Mustakallio K.K.

Controversies in bullous pyoderma gangrenosum, plaque-like cutaneous mucinosis and malignant pyoderma
pp. 33-33(1)
Author: Perry H.O.

The dermatologist as clinical scientist
pp. 33-33(1)
Author: Shuster S.

Invasive-versus non-invasive testing in control of systemic therapy in psoriasis
pp. 33-33(1)
Author: Zachariae H.

Basic science at the bedside
pp. 33-34(2)
Author: de Moragas J.M.

Current aspects of retinoid metabolism and binding to nuclear receptors
pp. 34-34(1)
Author: Vahlquist A.

In vitro screening of retinoids for their activity in psoriasis and acne
pp. 34-34(1)
Authors: Zouboulis C.C.; Seltmann H.; Xia L.; Chen W.-C.; Akamatsu H.; Sass J.O.; Ruhl R.; Plum C.; Seiffert K.; Nau H.; Orfanos C.E.

New concepts for delivery of topical retinoids
pp. 34-34(1)
Author: Shroot B.

Retinoids in dermatotherapy today
pp. 34-34(1)
Author: Gollnick H.

Retinoids in combined schedules
pp. 34-35(2)
Author: van de Kerkhof P.C.M.

Topical retinoids in ageing and cancer prevention
pp. 35-35(1)
Author: Saurat J.-H.

New topical retinoids for disorders of keratinization
pp. 35-35(1)
Author: Marks R.

What is the future of retinoids?
pp. 35-35(1)
Author: Orfanos C.E.

Practical management of hyperkeratotic skin conditions including the use of retinoids
pp. 35-36(2)
Author: Lacour M.

The importance of contactcryosurgery in early therapy of haemangiomas in infancy
pp. 36-36(1)
Authors: Cremer H.; Djawari D.

Update on the management of scabies and other infestations
pp. 36-36(1)
Authors: Gelmetti C.; Speich S.; Veraldi S.

Update on the management of warts and mollusca
pp. 36-36(1)
Author: Paige D.G.

Cutaneous lesions in neonatology: The reality
pp. 36-37(2)
Author: Lacour M.

Neurocutaneous interactions - general aspects
pp. 37-37(1)
Authors: Ansel J.C.; Olerud J.; Armstrong C.A.; Caughman S.W.; Bunnett N.

Neuropeptides and skin inflammation
pp. 37-37(1)
Author: Pincelli C.

Immunomodulating function of neuro-hormones
pp. 37-37(1)
Author: Luger T.A.

Neuropeptides in sweat production
pp. 37-37(1)
Author: Eedy D.J.

Neurohormones and skin diseases
pp. 37-38(2)
Author: Johansson O.

Neuropeptides in skin therapy
pp. 38-38(1)
Author: Lotti T.M.

How important is latex in the industrial environment?
pp. 38-38(1)
Author: Turjanmaa K.

Improving the ingredient labelling of industry products
pp. 38-38(1)
Authors: Menne T.; Flyvholm M.-A.

Preventing and curing dermatomyces in industries at risk
pp. 38-39(2)
Author: Hay R.J.

Recent data on airborne contact dermatitis
pp. 39-39(1)
Author: Lachapelle J.M.

New findings in metalworking fluid dermatitis
pp. 39-39(1)
Author: Rycroft R.J.G.

Dermato-epidemiology and everyday clinical practice
pp. 39-39(1)
Author: Williams H.C.

Doctor, what causes my skin disease?
pp. 39-39(1)
Authors: Grob J.J.; Richard M.A.; Martin S.

Will my skin disease get better, doctor?
pp. 40-40(1)
Author: Svensson A.

Dermatoepidemiology and future clinical practice
pp. 40-40(1)
Author: Elsner P.

Childhood urticaria
pp. 40-40(1)
Author: Black A.K.

Autoantibodies directed against FcRI: IgG subtype composition, prevalence, and disease specificity
pp. 40-41(2)
Authors: Fiebiger E.; Hammerschmid F.; Stingl G.; Maurer D.

Immunotherapy of chronic urticaria
pp. 41-41(1)
Author: O'Donnell B.F.

Drug therapy for urticaria
pp. 41-41(1)
Author: Juhlin L.

Inflammatory cells and CD34 expression in chronic urticaria
pp. 41-41(1)
Author: Vena G.A.

Advances in the prevention and treatment of cytomegalovirus (CMV) disease
pp. 41-41(1)
Author: Polsky B.

Epidemiology of opportunistic infection in Europe
pp. 41-42(2)
Author: Benfield T.L.

Fungial infections in AIDS
pp. 42-42(1)
Author: Powderly W.G.

Application of pharmacokinetics in the management of HIV patients
pp. 42-42(1)
Author: Barry M.

Update on pneumocystosis
pp. 42-42(1)
Author: Murphy R.L.

Current concepts of rosacea pathogenesis
pp. 42-42(1)
Author: Powell F.C.

Flushing and rosacea
pp. 42-43(2)
Author: Wilkin J.K.

The gastrointestinal tract and rosacea
pp. 43-43(1)
Author: Rebora A.

Granulomatous rosacea
pp. 43-43(1)
Author: Buechner S.A.

Laser therapy of rosacea
pp. 43-43(1)
Author: Lemarchand-Venencie F.

Contact urticaria to natural rubber latex proteins
pp. 43-43(1)
Author: Turjanmaa K.

Contact urticaria to protein hydrolysates
pp. 44-44(1)
Authors: Niinimaki A.; Niinimaki M.; Makinen-Kiljunen S.; Hannuksela M.

Studies on non-immunologic immediate contact reactions
pp. 44-44(1)
Authors: Wilhelm K.-P.; Wilhelm D.; Basketter D.A.

Contact urticaria and dermatitis to caterpillars and butterflies
pp. 44-44(1)
Author: Ducombs G.

Occupational contact urticaria
pp. 44-44(1)
Author: Kanerva L.

New issues in contact urticaria
pp. 45-45(1)
Author: Lahti A.

Contact urticaria syndrome: Where are we going?
pp. 45-45(1)
Author: Maibach H.I.

The role of HHV-8 for the pathogenesis of Kaposi's sarcoma
pp. 45-45(1)
Author: Weiss R.A.

Classical Kaposi's sarcoma in Greece: Clinical-epidemiological data
pp. 45-45(1)
Author: Stratigos J.D.

Development and clinical course of HIV-associated Kaposi's sarcoma: Significance of HIV-viral load and HIV-subtypes
pp. 45-46(2)
Authors: Husak R.; Wolfer L.-U.; Orfanos C.E.

New insights in the differences between classical and HIV-associated Kaposi's sarcoma
pp. 46-46(1)
Authors: Cerimele D.; Cottoni F.

The therapy of Kaposi's sarcoma: Current status and future directions
pp. 46-46(1)
Author: Brambilla L.

Epidemiology of genital papillomavirus infection
pp. 46-47(2)
Author: Paavonen J.

Clinical management of HPV disease in men
pp. 47-47(1)
Author: von Krogh G.

Vaccination against human papillomaviruses
pp. 47-47(1)
Author: Lacey C.J.N.

A rule concerning the segmental manifestation of autosomal dominant skin disorders
pp. 47-47(1)
Author: Happle R.

Mottled and reticulate pigmentation of the neck: Clue for rare genodermatoses
pp. 48-48(1)
Author: Itin P.H.

Recent advances in the molecular understanding of epidermolysis bullosa
pp. 48-48(1)
Authors: Eady R.A.J.; McGrath J.A.

The molecular pathology of the lamellar ichthyoses: The Dutch experience
pp. 48-48(1)
Authors: Steijlen P.M.; Melchers D.; van de Kerkhof P.C.M.; Kremer H.

The genetics of psoriasis: Where are we now?
pp. 48-48(1)
Author: Traupe H.

Non-melanoma skin cancer and epidemiology
pp. 49-49(1)
Author: Frentz G.

Non melanoma skin cancer and genes
pp. 49-49(1)
Author: Happle R.

Non-melanoma skin cancer (NMSC) and immunology
pp. 49-49(1)
Author: Krutmann J.

Nonmelanoma skin cancer and prevention
pp. 49-50(2)
Author: Rampen F.H.J.

Non melanoma skin cancer and treatment strategies
pp. 50-50(1)
Author: Andreassi L.

Cosmetics in dermatology
pp. 50-50(1)
Author: Lecha M.

Fragrances and cosmetics
pp. 50-50(1)
Author: Larsen W.G.

Irritant capacity of cosmetic formulations: A physico-chemical approach to minimize it in the case of anionic surfactants
pp. 50-50(1)
Authors: Vilaplana J.; Coll J.; Trullas C.; Lecha M.

Cosmetics for nails
pp. 50-50(1)
Authors: Tosti A.; Piraccini B.M.; Parente G.; Cavalli M.

Management of aging skin
pp. 51-51(1)
Author: Ghersetich I.

Dry skin, water and lubricants
pp. 51-51(1)
Author: Figueiredo A.

A dermatological viewpoint of stress & hormones in dermatology
pp. 51-51(1)
Author: Cotterill J.A.

Stress in dermatology: A psychiatric point of view
pp. 51-51(1)
Author: Musalek M.

Stress, psychotherapist and the psychotherapeutic view
pp. 51-52(2)
Author: Consoli S.G.

Dermatological psychoneuroendocrine immunology
pp. 52-52(1)
Author: Lotti T.M.

Stress and psoriasis: A psychological point of view
pp. 52-52(1)
Author: de Korte J.

Stress and endocrine reactions in eczema
pp. 52-52(1)
Authors: Gieler U.; Niemeier V.; Stangier U.

Stress as a factor in cutaneous surgery
pp. 52-52(1)
Author: Millard L.G.

Diagnosis of cutaneous drug reactions: Reality and perspectives
pp. 52-53(2)
Authors: Merk H.F.; Sieben S.; Jugert F.; Kawakubo Y.; Hertl M.

Type of skin reaction to carbamazepine is determined by type of immunologic response
pp. 53-53(1)
Authors: Pasmans S.G.M.A.; Bruijnzeel-Koomen C.A.F.M.; van Reijsen F.C.

Dress: Drug rash with eosinophilia and systemic symptoms
pp. 53-53(1)
Author: Revuz J.

Treatment of toxic epidermal necrolysis. Do corticosteroids help?
pp. 53-53(1)
Authors: Ioannides D.; Vareltzides A.

Drugs and nails
pp. 53-54(2)
Author: Rigopoulos D.

Drug-induced bullous disorders
pp. 54-54(1)
Authors: Bauer J.W.; Breathnach S.M.; Hintner H.

Epidemiology of genital herpes infection in Europe
pp. 54-54(1)
Author: Brugha R.F.

Viral shedding from patients with genital HSV infection: What do we mean?
pp. 54-54(1)
Author: Barton S.E.

New antivirals - Implications for treatment of genital herpes
pp. 54-54(1)
Author: Cowan F.M.

Vaccines against HSV - Who, how and when?
pp. 54-55(2)
Author: Stanberry L.R.

What about the patient? The patient's state of mind
pp. 55-55(1)
Author: Green J.

1997 perspective of genital herpes. What about the patient?
pp. 55-55(1)
Author: Kroon S.

Oral manifestations of dermatological diseases
pp. 55-55(1)
Author: Lamey P.J.

Behcet's disease
pp. 55-55(1)
Author: Jorizzo J.L.

Autoantigens of oral epithelium
pp. 55-55(1)
Author: Anhalt G.J.

Oral tumors in HIV infection
pp. 56-56(1)
Author: Ficarra G.

Oral candidosis
pp. 56-56(1)
Author: Flint S.R.

What's new in European dermatology
pp. 56-56(1)
Author: Hawk J.L.M.

What's new in skin cancer
pp. 56-56(1)
Author: Rees J.L.

What's new in genetic skin disease?
pp. 56-56(1)
Author: McGrath J.A.

What's new in autoimmunity?
pp. 56-57(2)
Author: Stingl G.

What's new in keratinocyte biology?
pp. 57-57(1)
Author: Leigh I.M.

What's new in photobiology
pp. 57-57(1)
Author: Schwarz T.

SDZ ASM 981 - A novel anti-inflammatory macrolactam
pp. 57-57(1)
Authors: Stutz A.; Grassberger M.; Meingassner J.G.

Existence of a possible link between anti H₁ and antiinflammatory activities
pp. 57-58(2)
Authors: Ramboer I.; Rihoux J.P.

The vitamin D-cascade. Biological role of metabolites in human keratinocytes
pp. 58-58(1)
Authors: Schuster I.; Astecker N.; Egger H.; Reddy S.; Herzig G.; Schmid H.; Vorisek G.

Lymphoproliferative disorders
pp. 59-59(1)
Author: O'Keane J.C.

Vasculitis: A differential diagnostic approach
pp. 59-59(1)
Author: Zelger B.

Histopathology of the alopecias
pp. 59-59(1)
Author: Cerio R.

Differential diagnosis of auto-immune subepidermal blisters
pp. 59-60(2)
Author: McKee P.H.

Childhood mastocytosis
pp. 60-60(1)
Author: Oranje A.P.

Langerhans cell histiocytosis in children
pp. 60-60(1)
Author: Cambazard F.

Atopic eczema in Russia
pp. 60-60(1)
Authors: Toropova N.P.; Sinyavskaya O.A.; Gradinarov A.M.; Zelinskaya D.I.

Paediatric HIV infection
pp. 60-61(2)
Author: Butler K.M.

Update on keratin disorders
pp. 61-61(1)
Author: Steijlen P.M.

Management of basal cell carcinoma. Surgical procedures
pp. 61-61(1)
Author: Camacho F.M.

Management of squamous cell carcinoma: Surgical procedures
pp. 61-61(1)
Authors: Petres J.; Rompel R.

Management of actinic keratosis and other pre-cancerous processes
pp. 61-62(2)
Author: Neumann H.A.M.

Epidemiology of squamous cell carcinoma
pp. 62-62(1)
Authors: Guillen C.; Botella R.; Escudero A.; Sanmartin O.

What is new: Diagnosis and treatment of cutaneous malignancy
pp. 62-62(1)
Author: Holt P.J.A.

Education in skin cancer
pp. 62-62(1)
Author: Robins P.

Radiotherapy of benign and premalignant skin diseases
pp. 62-62(1)
Author: Panizzon R.G.

Electron therapy for skin tumours
pp. 62-62(1)
Author: Spittle M.F.

Cosmetic dermatologic surgery course
pp. 63-63(1)
Author: Roseeuw D.

Mechanisms of ageing
pp. 63-63(1)
Authors: Pierard G.E.; Pierard-Franchimont C.

Light peelings
pp. 63-63(1)
Author: Ghersetich I.

Skin resurfacing
pp. 63-63(1)
Author: Letessier S.

Facial mole surgery for cosmetic purposes
pp. 63-63(1)
Author: Landi G.

The principle ideas of molecular biology
pp. 64-64(1)
Author: McConnell D.J.

Molecular biology and medicine
pp. 64-64(1)
Author: Croke D.T.

Bioinformatics and molecular biology
pp. 64-64(1)
Author: Lloyd A.T.

Applications of molecular biology to dermatology and/or venereology
pp. 64-64(1)
Author: Teofoli P.

Biological effects and cellular responses to UV radiation
pp. 64-65(2)
Author: Schwarz T.

The molecular bases of tanning
pp. 65-65(1)
Author: Ortonne J.-P.

Photoageing and chronic effects
pp. 65-65(1)
Author: Garmyn M.

Mechanisms of UV carcinogenesis
pp. 65-65(1)
Authors: de Gruijl F.R.; Berg R.J.W.; van Steeg H.; van Kranen H.J.

Sunlight and skin cancer
pp. 65-66(2)
Author: Marks R.

Useful patch test batteries
pp. 66-66(1)
Author: Andersen K.E.

The use of patch-test batteries: Pros and cons
pp. 66-66(1)
Author: Goossens A.

Series for shoes and clothing dermatitis
pp. 66-66(1)
Author: Podmore P.

Patch test battery for plastics
pp. 66-67(2)
Authors: Kanerva L.; Jolanki R.; Estlander T.

Photopatch testing
pp. 67-67(1)
Author: Ferguson J.

Patch test batteries for plant dermatitis
pp. 67-67(1)
Author: Paulsen E.

Epidemiology and investigation of leg ulcers
pp. 67-67(1)
Author: Neumann H.A.M.

Microcirculatory disturbances in venous leg ulcers. Facts and therapeutic consequences
pp. 67-68(2)
Authors: Junger M.; Klyscz T.; Hahn M.; Steins A.; Zuder D.

Lymphoedema associated with venous disease with and without ulceration
pp. 68-68(1)
Author: Mortimer P.S.

Compression, general and local therapy of leg ulcers
pp. 68-68(1)
Author: Partsch H.

New dressing for leg ulcers
pp. 68-68(1)
Author: Degreef H.

Dermatosurgical and surgical approach to venous ulcers
pp. 68-68(1)
Author: Ramelet A.-A.

Shave therapy for persistent venous ulcers
pp. 69-69(1)
Author: Schmeller W.

Abnormal effects of UVR
pp. 69-69(1)
Author: Hawk J.L.M.

Chronic actinic dermatitis
pp. 69-69(1)
Author: du Menage H.

Solar urticaria - Pathogenesis and management
pp. 69-69(1)
Author: Murphy G.M.

Drug and chemical photosensitivity
pp. 69-69(1)
Author: Ferguson J.

The common cutaneous porphyrias
pp. 70-70(1)
Authors: Herrero C.; Lecha M.

DNA repair deficient disorders
pp. 70-70(1)
Author: Epstein J.H.

Phototherapy for the photodermatoses
pp. 70-70(1)
Author: Marguery M.C.

Langerhans cells and the skin immune system
pp. 70-70(1)
Author: Braathen L.R.

Mediators of immunity and inflammation
pp. 70-71(2)
Author: Luger T.A.

Melanoma - Immunotherapy
pp. 71-71(1)
Author: Stingl G.

Immunomodulatory drugs
pp. 71-71(1)
Author: Reitamo S.

Skin signs of immunodeficiency
pp. 71-71(1)
Author: Maurer D.

Immunology of psoriasis
pp. 71-72(2)
Author: Barker J.N.W.N.

The spectrum of lupus erythematosus
pp. 72-72(1)
Author: Bos J.D.

Bullous autoimmune diseases
pp. 72-72(1)
Authors: Hintner H.; Bauer J.W.

Can we prevent contact dermatitis?
pp. 72-72(1)
Author: Diepgen T.L.

Can we prevent irritant contact dermatitis?
pp. 72-72(1)
Author: Basketter D.A.

How shall we organize prevention in the occupational setting?
pp. 72-73(2)
Author: Wahlberg J.E.

What can European institutions do to prevent contact dermatitis on the continent?
pp. 73-73(1)
Author: White I.R.

How can I, the dermatologist, prevent contact dermatitis in my daily practice?
pp. 73-73(1)
Author: Perrenoud D.

Photobiology course - Therapy with UV
pp. 73-73(1)
Author: Roelandts R.

Photodynamic therapy
pp. 73-73(1)
Authors: Szeimies R.-M.; Landthaler M.

TL-01: A comparison with conventional broadband UVB/PUVA
pp. 74-74(1)
Author: Ferguson J.

Indications for UVA 1 phototherapy
pp. 74-74(1)
Author: Krutmann J.

Photobiology; Increasing the efficacy by using combinations
pp. 74-74(1)
Author: van de Kerkhof P.C.M.

Drug-induced photosensitivity
pp. 74-74(1)
Author: DeLeo V.A.

Photoprovocation of idiopathic photodermatoses
pp. 74-75(2)
Author: Beani J.C.

Investigation of photodermatoses
pp. 75-75(1)
Author: Roelandts R.

Photopatch testing
pp. 75-75(1)
Author: Holzle E.

Assessment of skin type
pp. 75-75(1)
Author: Wulf H.C.

UV measurements
pp. 75-75(1)
Author: de Gruijl F.R.

Patch testing with TRUE test
pp. 76-76(1)
Author: Kreilgard B.

Problems in patch testing: Multiple reactions, what might they mean?
pp. 76-76(1)
Author: Rietschel R.L.

Fragrance allergic contact dermatitis and testing with commercially available fragrances
pp. 76-76(1)
Authors: Johansen J.D.; Menne T.; Rastogi S.C.; Andersen K.E.

Cosmetic contact dermatitis
pp. 76-76(1)
Author: Perrenoud D.

Contact dermatitis to sunscreen agents
pp. 76-76(1)
Author: Goncalo M.

Contact dermatitis to corticosteroids
pp. 77-77(1)
Author: Wilkinson S.M.

Childhood sexually transmitted disease and abuse
pp. 79-79(1)
Author: Robinson A.J.

Lichen sclerosis: Progress in our understanding of this disease
pp. 79-79(1)
Author: Marren P.

Vulval lichen planus
pp. 79-79(1)
Author: Pelisse M.

Vulval intraepithelial neoplasia III
pp. 80-80(1)
Author: Edwards A.

Herpes simplex virus infection of the genitals
pp. 80-80(1)
Author: Barton S.E.

Vulvodynia - New concepts
pp. 80-80(1)
Author: Neill S.M.

Post surgical nail malalignment
pp. 80-80(1)
Authors: Baran R.; de Berker D.A.R.

Surgical treatment of the dorsal myxoid pseudocyst
pp. 80-80(1)
Author: Haneke E.

A new noninvasive method for the treatment of ingrown toenails
pp. 81-81(1)
Authors: Schulte K.W.; Neumann N.J.; Hundeiker M.; Ruzicka T.

Problem solving in nail surgery
pp. 81-81(1)
Authors: Baran R.; Haneke E.

Fragrance update
pp. 81-81(1)
Author: Larsen W.G.

Prevention of fragrance allergy
pp. 81-81(1)
Authors: European Fragrance Study Group; Menne T.; Johansen J.D.

Fragrance regulations in Europe
pp. 81-81(1)
Author: White I.R.

History of dermatology symposium - An introduction
pp. 82-82(1)
Author: Holubar K.

The dermatological/medical and human experiences of Diaz d'Ysla on syphilis
pp. 82-82(1)
Author: Ricon-Ferraz A.

Syphilization - ''Vaccination'' against syphilis in the 19th century in Norway
pp. 82-82(1)
Author: Fyrand O.

Skin diseases mentioned by Shakespeare
pp. 82-82(1)
Author: Goens J.

History of erythema nodosum
pp. 82-83(2)
Author: Durand C.

The destiny of the Jewish dermatologists in Germany in the time of Nationalsocialism
pp. 83-83(1)
Authors: Eppinger S.; Scholz A.

Human papillomavirus (HPV) and cutaneous warts
pp. 83-83(1)
Authors: Harwood C.A.; Breuer J.; McGregor J.M.; Proby C.M.; Leigh I.M.

Human papillomavirus DNA in malignant and premalignant skin lesions of renal transplant recipients
pp. 83-83(1)
Authors: de Jong-Tieben L.M.; Bavinck J.N.B.; Berkhout R.J.M.; ter Schegget J.

UV and p53 mutations in post-transplant skin cancer
pp. 83-83(1)
Author: McGregor J.M.

Bee and wasp allergy - Clinical picture and diagnosis
pp. 84-84(1)
Author: Przybilla B.

Intracavernosal injection of prostaglandin E1
pp. 84-84(1)
Authors: Menchini-Fabris F.; Rossi P.; Simi S.; Fiorini I.

Intraurethral therapy for erectile dysfunction
pp. 84-84(1)
Author: Kell P.

Oral drugs for erectile dysfunction
pp. 84-84(1)
Author: Montorsi F.

Sildenafil - Recent developments
pp. 84-85(2)
Author: Dinsmore W.W.

Session on general surgical technique
pp. 85-85(1)
Authors: Camps-Fresneda A.; Walker N.

Wound closure techniques
pp. 85-85(1)
Author: Vilalta A.

Cryosurgery for benign lesions
pp. 85-85(1)
Author: Colver G.

Regional anaesthesia
pp. 85-85(1)
Author: Holt P.J.A.

Laser safety - A physicist's view
pp. 85-85(1)
Author: Gillan I.T.F.

Who should be using a grade IV laser? What training should users have?
pp. 85-85(1)
Author: Cotterill J.A.

Laser safety: Safety factors in pain
pp. 86-86(1)
Author: Allen G.E.

Photodynamic therapy of skin tumours using ALA cream and red light
pp. 86-86(1)
Authors: Leite L.; Cochito M.; Lopes C.

Future directions in photodynamic therapy
pp. 86-86(1)
Author: Grevelink J.M.

Sunbeds - Adverse effects
pp. 86-86(1)
Author: DeLeo V.A.

How to measure percutaneous absorption
pp. 86-86(1)
Author: Marty J.P.

Stratum corneum structure and penetration
pp. 86-87(2)
Authors: Fartasch M.; Sugar M.; Schnetz E.

Percutaneous penetration in atopic skin
pp. 87-87(1)
Author: Turpeinen M.

Percutaneous absorption in psoriatic skin
pp. 87-87(1)
Authors: Surber C.; Schwarb F.

Relevance of percutaneous penetration for the clinical dermatologist
pp. 87-87(1)
Author: Maibach H.I.

Phenotypic and T-cell receptor repertoire analysis of CD8+ T-cells in psoriatic arthritis
pp. 87-87(1)
Authors: Costello P.; Kane D.; Bresnihan B.; Winchester R.J.; FitzGerald O.

Management of patients with red faces
pp. 87-88(2)
Author: Marks R.

Sentinel node biopsy in malignant melanoma
pp. 88-88(1)
Author: Rock B.M.

Scientific basis of cryosurgery
pp. 88-88(1)
Author: Dawber R.P.R.

Current developments and uses of cryosurgery in the treatment of keloids and hypertrophic scars
pp. 88-88(1)
Authors: Zouboulis C.C.; Zouridaki E.; Rosenberger A.; Wulff A.; Orfanos C.E.

Cryotherapy of viral warts
pp. 88-88(1)
Author: Berth-Jones J.

Practical treatment schedules for Bowen's disease and cutaneous malignancy
pp. 88-89(2)
Authors: Ball S.; Dawber R.P.R.

Introduction to the classification of the specific dermatoses of pregnancy
pp. 89-89(1)
Author: Black M.M.

Pemphigoid gestationis - Update
pp. 89-89(1)
Author: Jenkins R.E.

PUPPP or polymorphic eruption of pregnancy
pp. 89-89(1)
Author: Powell F.C.

Pruritic urticarial papules and plaques of pregnancy
pp. 89-90(2)
Author: Lawley T.J.

Specific pruritic diseases of pregnancy. A prospective study of 3192 pregnant women
pp. 90-90(1)
Authors: Roger D.; Vaillant L.

Papular dermatitis of pregnancy (PDP) - Spangler: True or false?
pp. 90-90(1)
Author: Jones S.A.V.

Atypical autoimmune subepidermal blistering disorders of pregnancy
pp. 90-90(1)
Authors: Borradori L.; Saurat J.-H.

Physical measurement in allergic contact dermatitis in the future
pp. 90-91(2)
Author: Wahlberg J.E.

Physical measurement in allergic contact dermatitis
pp. 91-91(1)
Authors: Di Nardo A.; Seidenari S.

Physical measurement in irritant contact dermatitis
pp. 91-91(1)
Author: Ramsing D.W.

Standardization of transepidermal water loss (TEWL) measurement
pp. 91-91(1)
Author: Tupker R.A.

Standardization of skin colour and cutaneous blood flow measurements
pp. 91-91(1)
Author: Fullerton A.

Physical measurements for predictive evaluation of tolerability of cosmetic products
pp. 91-92(2)
Author: Zuang V.

Morphea and localized sclerodema: Introduction
pp. 92-92(1)
Author: Rufli T.

The clinical spectrum of morphea
pp. 92-92(1)
Authors: Blaszczyk M.; Jablonska S.

Infection and scleroderma - A possible relationship
pp. 92-92(1)
Authors: Krieg T.; Sollberg S.; Eckes B.

Diagnostic procedures in borrelia infection
pp. 92-93(2)
Author: Neubert U.

Lymphoproliferative responses to Borrelia burgdorferi in morphea and localized scleroderma
pp. 93-93(1)
Author: Buechner S.A.

The pathophysiology of mastocytosis
pp. 93-93(1)
Authors: Zuberbier T.; Buttner C.; Grabbe J.; Henz B.M.

Clinical and molecular correlates of mastocytosis
pp. 93-93(1)
Author: Greaves M.W.

Topical steroids and mastocytosis
pp. 93-93(1)
Author: Thestrup-Pedersen K.

The prognosis of mastocytosis
pp. 93-94(2)
Authors: van Doormaal J.J.; Elberink J.N.G.O.; Kors J.W.; Dubois A.E.J.; de Monchy J.G.R.

The melanocyte reservoir in human skin
pp. 94-94(1)
Author: Ortonne J.-P.

Replacing the reservoir: Small areas
pp. 94-94(1)
Author: Gauthier Y.

Vitiligo. Recent advances replacing the reservoir: Large areas
pp. 94-94(1)
Authors: Juhlin L.; Olsson M.

Antioxidants in the treatment of vitligo
pp. 94-95(2)
Author: Schallreuter-Wood K.U.

Immunological approaches in the treatment of vitiligo
pp. 95-95(1)
Author: Westerhof W.

Structural overview of the skin
pp. 95-95(1)
Author: Eady R.A.J.

Structural abnormalities of dermis in disease
pp. 95-95(1)
Authors: MRC Connective Tissue Genetics Group; Burrows N.P.

Enzyme defects in connective tissue disorders
pp. 95-95(1)
Author: Lapiere C.M.

Inherited abnormalities of connective tissue (IDCT)
pp. 95-96(2)
Author: Pope F.M.

Skin and HIV infection, an overview
pp. 96-96(1)
Author: Hulsebosch H.J.

Psoriasis and HIV
pp. 96-96(1)
Author: Staughton R.C.D.

Treatment options for HSV and VZV infections
pp. 96-96(1)
Author: Cusini M.

Treatment options for fungal infections
pp. 96-96(1)
Author: Delescluse J.

Recent review of the internal medicine literature
pp. 97-97(1)
Author: Callen J.P.

Urticaria - Systemic associations
pp. 97-97(1)
Author: O'Loughlin S.

Disease spectrum of anti-RO (SS-A) antibody positive patients
pp. 97-97(1)
Author: Watson R.

Dermatomyositis update - 1997
pp. 97-97(1)
Authors: Jorizzo J.L.; Dawkins M.A.

Systemic aspects of medical management of erythrodermic psoriasis
pp. 97-98(2)
Author: Lyons F.

Laser treatment of congenital vascular naevi
pp. 98-98(1)
Author: Monk B.

A review of treatment of pigmented lesions and tattoos
pp. 98-98(1)
Author: Lanigan S.W.

The Erb:Yag-laser - A new technique in skin-photoablation
pp. 98-98(1)
Author: Tiel H.

Hair removal
pp. 98-98(1)
Author: Cotterill J.A.

Solar keratosis is squamous cell carcinoma
pp. 98-99(2)
Author: Ackerman A.B.

Anti infective drugs are not useful in the management of common atopic dermatitis
pp. 99-99(1)
Author: Revuz J.

The usefulness of antiinfective treatment in the management of atopic dermatitis
pp. 99-99(1)
Author: Taieb A.

Exploding myths about melanoma
pp. 99-99(1)
Author: Ackerman A.B.

Law and ethics - How do they affect clinical practice?
pp. 99-99(1)
Author: Young M.

1. Dithranol and psoriasis - Why do we settle for second best? 2. Aging & retinoids, who's fooling who?
pp. 99-99(1)
Author: Shuster S.

Vasculitis - Clinical update
pp. 100-100(1)
Authors: Diaz-Perez J.L.; Tosta A.

Pathogenesis
pp. 100-100(1)
Author: Fritsch P.

Small vessel vasculitis
pp. 100-100(1)
Author: Lotti T.M.

ANCA-associated vasculitides
pp. 100-100(1)
Author: Gross W.L.

Treatment of vasculitides
pp. 100-100(1)
Author: Tosca A.D.

Aids & the skin - What's on
pp. 101-101(1)
Author: Staughton R.C.D.

Skin cancer in PUVA patients
pp. 101-101(1)
Author: McGregor J.M.

The skin in organ transplant recipients
pp. 101-101(1)
Author: Euvrard S.

New pigmentary disorders
pp. 101-101(1)
Author: Ortonne J.-P.

New techniques for the clinical evaluation of pigmentary disorders
pp. 101-101(1)
Authors: Naeyaert J.M.; Haeghen Y.V.

New treatment procedures of pigment diseases
pp. 102-102(1)
Author: Westerhof W.

Chemical peelings for the treatment of melasma
pp. 102-102(1)
Authors: Katsambas A.D.; Syngros A.

Melanocyte stimulating hormone, its receptors and pigmentation of the skin
pp. 102-102(1)
Author: Thody A.J.

Sunscreen use and usefulness
pp. 102-102(1)
Author: Wulf H.C.

The use of hydroxychloroquine in the management of photosensitive skin disease
pp. 102-103(2)
Author: Ferguson J.

Systemic UV protection of -carotene in photodermatoses and normal skin
pp. 103-103(1)
Author: Bech-Thomsen N.

Thalidomide in photosensitivity
pp. 103-103(1)
Author: Hawk J.L.M.

Cyclosporin and prednisolone in photodermatoses
pp. 103-103(1)
Author: Jeanmougin M.

Therapeutic expression of cytokines in epidermis following injection of naked DNA
pp. 104-104(1)
Authors: Hengge U.R.; Goos M.; Vogel J.C.

Recent advances in the gene therapy of junctional epidermolysis bullosa
pp. 104-104(1)
Author: Meneguzzi G.

Gene therapy of skin cancer
pp. 104-104(1)
Author: Stingl G.

The impact of genomics on drug discovery: Prospects for improved treatment of dermatological diseases
pp. 104-105(2)
Author: Meyers N.L.

Telemedicine - An overview
pp. 105-105(1)
Author: Wootton R.

On-line atlas as a tool for teledermatology
pp. 105-105(1)
Authors: Diepgen T.L.; Bauer J.; Simon M.; Bittorf A.

Still image-based dermatological diagnosis in a semi-rural setting
pp. 105-105(1)
Author: Harrison P.V.

The UK multicentre teledermatology study I
pp. 105-106(2)
Author: Gore H.E.

The UK teledermatology study II
pp. 106-106(1)
Author: Gilmour E.

Real time teledermatology using ISDN6
pp. 106-106(1)
Author: Suhonen R.

Genital dermatoses - Introduction
pp. 106-106(1)
Author: Waugh M.A.

Genitoanal lesions as manifestation of generalized dermatoses
pp. 106-106(1)
Author: Kohl P.K.

Genitoanal lesions in Adamantiades-Behcet's disease
pp. 106-107(2)
Author: Zouboulis C.C.

Differential diagnosis of genitoanal pigmentations
pp. 107-107(1)
Author: Sacerdoti G.

Indications for biopsy and surgery of genitoanal lesions: A dermatohistologist's view
pp. 107-107(1)
Author: Krahl D.

Management of genitoanal pruritus
pp. 107-107(1)
Author: O'Loughlin S.

The problem of litigation in dermatological practice
pp. 107-108(2)
Author: Cotterill J.A.

Communication in dermatology and defensive dermatology?
pp. 108-108(1)
Author: Cotterill J.A.

Pointers in negligence
pp. 108-108(1)
Authors: Tomkin D.N.; Mc Auley A.

The problem from the point of view of the medical defence organisation
pp. 108-108(1)
Author: Norwell N.

The expert witness
pp. 108-108(1)
Author: Young M.

The microbiology and odour formation in the axilla
pp. 109-109(1)
Author: Holland K.T.

Treatment of localized hyperhidrosis with aluminium-chlorid-solutions and tapwater iontophoresis
pp. 109-109(1)
Author: Holzle E.

Thoracoscopic sympathectomy for treatment of hyperhidrosis
pp. 109-109(1)
Authors: Graham A.N.J.; McGuigan J.A.

Measurement of photodamage therapies
pp. 109-109(1)
Author: Marks R.

Techniques of image enhancement and analysis for area and severity assessments of skin disease
pp. 109-110(2)
Author: Edwards C.

Instrumental evaluation of skin color and assessment of melanoma risk
pp. 110-110(1)
Authors: Andreassi L.; Flori M.L.; Rubegni P.; Cevenini G.; Fimiani M.

Transepidermal water loss (TEWL)/percutaneous absorption (PA) relationship
pp. 110-110(1)
Author: Rougier A.

Suction methods in the measurement of connective tissue disorders
pp. 110-110(1)
Author: Pierard G.E.

Measurements on the Stratum Corneum: Disease and normal
pp. 110-110(1)
Author: Leveque J.L.

Clinical uses of skin hydration assessments
pp. 111-111(1)
Author: Elsner P.

Quantitative assessment of diseases
pp. 111-111(1)
Author: Seidenari S.

Standardisation of sun protection factors
pp. 111-111(1)
Author: Ferguson J.

Controversies in European legislation
pp. 111-111(1)
Author: White I.R.

Neurones and the skin - Future of neuro-dermato-cosmetology
pp. 113-113(1)
Author: Lotti T.M.

Psoriasis - Therapeutic dilemma and solutions
pp. 113-113(1)
Authors: Murphy G.M.; Holze E.

Bacteria and the skin - Clinical practice and therapy update
pp. 113-113(1)
Author: Thestrup-Pedersen K.

Genital warts: A recurring problem - Imiquimod a new approach to treatment
pp. 113-114(2)
Author: Maw R.D.

Tazarotene: A new topical receptor-selective retinoid
pp. 114-114(1)
Authors: Ortonne J.-P.; Marks R.

The compliance of science
pp. 114-114(1)
Author: Finlay A.Y.

Male androgenetic alopecia: A new treatment paradigm
pp. 114-114(1)
Author: Dawber R.

Chilblain lupus erythematosus: Report of 5 cases
pp. 115-115(1)
Authors: Pramatarov K.; Gantcheva M.

Th2 involvement in the pathogenesis of bullous pemphigoid
pp. 115-115(1)
Authors: De Pita O.; Cianchini G.; Frezzolini A.; Ruffelli M.; Teofoli P.; Puddu P.

Keratinocytes secrete eotaxin and it is upregulated in bullous pemphigoid lesional epidermis
pp. 115-115(1)
Authors: O'Toole E.A.; Arami S.; Guitart J.; MacKay C.R.; Woodley D.T.; Chan L.S.

Type VII (anchoring fibril) collagen exists in human intestine and serves as an antigenic target in patients with inflammatory bowel disease
pp. 116-116(1)
Authors: Chen M.; O'Toole E.A.; Sanghavi J.; Mahmud N.; Weir D.; Kelleher D.; Woodley D.T.

Extensive necrobiotic granulomatous skin disease in association with common variable immunodeficiency
pp. 116-116(1)
Authors: O'Toole E.A.; Sweeney E.; Feighery C.; Barnes L.

Anti-laminin 5 cicatricial pemphigoid
pp. 116-116(1)
Authors: Reed J.; Sidhu S.; Wojnarowska F.; Young S.

Coexistence of myasthenia gravis and oral lichen planus with and without thymoma. Two cases
pp. 116-116(1)
Authors: Gimenez-Arnau A.; Pou A.; Camarasa J.G.

Vulval lichen sclerosus associated with morphoea or scleroderma
pp. 116-117(2)
Authors: Farrell A.M.; Marren P.; Wojnarowska F.

Epidermolysis bullosa acquisita associated with cryoglobulinemia and hepatitis C: Therapeutic response to interferon and ribavirin
pp. 117-117(1)
Authors: Misery L.; Thiery S.; Chossegros P.; Kanitakis J.; Forestier J.Y.; Faure M.; Claudy A.

A clinicopathological study of discoid lupus erythematosus
pp. 117-117(1)
Authors: Petronic-Rosic V.; Urosevic M.; Marinkovic J.; Minic S.; Vesic S.; Cvijetic O.

Localised morphoea, xanthomatosis, and primary biliary cirrhosis
pp. 117-117(1)
Authors: Reed J.; Ali M.; Young E.; Wilkinson J.

Oral erosive lichen planus: Its association with hepatitis C infection
pp. 117-118(2)
Authors: Egan C.A.; Zone J.J.

Inducible-nitric oxide synthase mRNA is expressed in lesional skin in scleroderma
pp. 118-118(1)
Authors: Teofoli P.; Lotti T.; De Pita O.; Cianchini G.; Cadoni S.; Puddu P.

Increased levels of prolactin in sera of female and male patients with systemic sclerosis
pp. 118-118(1)
Authors: Uhrynowska I.A.; Czuwara J.; Nowicka U.; Malejczyk M.; Makieta B.; Mackowiak M.; Gaciag Z.; Blaszczyk M.; Jablonska S.; Radowicki S.; Rudnicka L.

Partial lipodystrophy-2 established cases
pp. 118-118(1)
Authors: Lenane P.; Donohue J.D.; Murphy G.M.

Contact allergy from alkanolamines in metalworking fluids
pp. 118-119(2)
Authors: Jolanki R.; Alanko K.; Henriks-Eckerman M.-L.; Estlander T.; Kanerva L.

Anamnestical data as risk factors of allergic contact dermatitis
pp. 119-119(1)
Authors: Somov B.A.; Matveev N.V.

A fifteen year review of lanolin allergy
pp. 119-119(1)
Authors: Wakelin S.H.; McFadden J.; Holloway D.; Rycroft R.J.G.; White I.R.

The cytokine profile in nickel-induced contact dermatitis in atopic dermatitis patients and non-atopic individuals
pp. 119-119(1)
Authors: Szepietowski J.; McKenzie R.C.; Keohane S.G.; Aldridge R.D.; Hunter J.A.A.

Leukaemia inhibitory factor: Induction in the early phase of allergic contact dermatitis
pp. 119-119(1)
Authors: Szepietowski J.C.; McKenzie R.C.; Keohane S.G.; Walker C.; Aldridge R.D.; Hunter J.A.A.

Low intensity laser scanning of skin
pp. 120-120(1)
Authors: Shadiev H.K.; Shahabiddinov T.T.; Asedova K.A.

Dermatological challenges in the oil industry
pp. 120-120(1)
Author: Nyfors A.

Cyclosporin and phototherapy in the treatment of atopic dermatitis
pp. 120-120(1)
Authors: Flori M.L.; Micheli S.; Stanghellini E.; Molinu A.; Andreassi L.

Mixed malignant sweat gland tumor (report of a case and review of the literature)
pp. 120-120(1)
Authors: Bonvicino A.; Taraglio S.; Molinero A.; Tomidei M.; Strani G.F.

Sensitivity and specificity of paraffin O-10 monoclonal antibody in Langerhans cell histiocytosis (LCH): A comparative analysis with electron microscopy and other immunohistochemical stains
pp. 120-121(2)
Authors: O'Connor W.J.; Cheng J.; Kurtin P.J.; Ahmed I.

Lymphovenous surgery in treatment of postmastectomy-lymphedema
pp. 121-121(1)
Authors: Mulkens P.J.M.; Vernaus H.; Nieuborg L.; Kreysel H.W.

Nodular hidradenoma with mucinous syringometaplasia
pp. 121-121(1)
Authors: Bonvicino A.; Ravarino N.; Molinero A.; Tomidei M.; Strani G.F.

Efficacy, tolerability and safety of a long pulse Ruby laser system in the removal of unwanted hair by selective photothermolysis
pp. 121-121(1)
Authors: Polderman M.C.A.; Grevelink J.M.; Pavel S.; van Leeuwen R.L.

Thread vein treatment: Vascular response to modified Nd:YAG laser
pp. 121-121(1)
Authors: Harrison P.; West S.; Healy D.

The gamma-probe guided sentinel lymphonod ectomy in the primary therapy of malignant melanoma
pp. 122-122(1)
Authors: Bachter D.; Balda B.R.; Vogt H.; Buchels H.

Pulsed dye laser - Other therapeutic possibilities
pp. 122-122(1)
Authors: Hellwig S.; Raulin C.; Petzoldt D.

Chronic urticaria and helicobacter pylori infection
pp. 122-122(1)
Authors: Kalimo K.; Liutu M.; Leino R.; Uksila J.; Kalimo H.

Climatotherapy of psoriasis at the Dead Sea Spa Medical Center in Jordan
pp. 122-122(1)
Author: Bisharat Z.Z.

Improvement of functional disorders after surgery of the lesser saphenous vein
pp. 122-122(1)
Authors: Mulkens P.J.M.; Kluess H.G.; Prieur H.; Rabe E.; Kreysel H.W.

A comparison of two formulations of cyclosporin in severe psoriasis
pp. 123-123(1)
Authors: Multinational Neoral Investigators Group; Berth-Jones J.; Ruzicka T.

Effect of treatment on areas of life impaired by acne
pp. 123-123(1)
Authors: Dowsett J.; Newton J.N.

What is new in acne vulgaris treatment
pp. 123-123(1)
Authors: Katkhanov A.M.; Tlish M.M.

Cyclosporin (Sandimmun(R)) and Puva in the treatment of psoriasis
pp. 123-123(1)
Authors: Arifov S.; Vaisov A.; Abidova Z.; Rasulova N.; Ismagilov A.

Incidence of psoriatic arthropathy
pp. 123-124(2)
Author: Dupont C.

Treatment of psoriasis vulgaris by cadmium laser - A preliminary report
pp. 124-124(1)
Authors: Zalewska A.; Peszynski-Drews C.; Wolf L.; Omulecki A.

Comparative study of oral low-dose and high-dose isotretinoin in acne
pp. 124-124(1)
Authors: Lefaki I.; Karakatsanis G.; Vakali G.; Kapetis E.; Chaidemenos G.C.; Efthymiadou R.; Minas A.

An epidemiological survey about acne in a scholar population in France
pp. 124-124(1)
Authors: Daniel F.; Auffret N.; Beylot C.; Bodokh I.; Chivot M.; Dreno B.; Humbert P.; Meynadier J.; Poli F.; Clerson P.; Humbert R.

Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis
pp. 124-124(1)
Authors: Sefton J.; Lew-Kaya D.A.; Mierzwa M.; Vasilopoulos A.; Lue J.C.; Gibson J.R.

Comparison of liquid nitrogen cryotherapy with curettage in the treatment of Bowen's disease
pp. 125-125(1)
Authors: Ahmed I.; Berth-Jones J.; Charles-Holmes S.; Ilchyshyn A.

Pharmacoeconomic analysis of oral therapies for onychomycosis in the US
pp. 125-125(1)
Authors: Gupta A.K.; Oh P.I.; Rothman M.

Avene springwater spray is effective in the healing of face skin after chemical peeling
pp. 125-125(1)
Authors: Glogau R.; Licu D.; Brody H.; Fresneda A.C.; Carey W.; Rubin M.; Scorca L.R.; Dupuy P.

Clindamycin 1%/tretinoin 0.025% gel versus clindamycin 1% lotion in acne vulgaris
pp. 125-125(1)
Authors: Derumeaux L.; De Boulle K.; Roders G.A.; van Es-Gulinck M.K.

Linear fixed drug eruption
pp. 126-126(1)
Authors: Ozkaya-Bayazit E.; Baykal C.

Trichological microscopy in polarized light
pp. 126-126(1)
Authors: Marliani A.; Gigli P.; Salin M.

Hidradenitis suppurativa inducing secondary systemic amyloidosis - A case report
pp. 126-126(1)
Authors: Black R.J.; Scott K.W.; Allen D.E.

Zinc aspartate, biotin and clobetasol propionate in the treatment of alopecia areata in childhood
pp. 126-126(1)
Authors: Garcia-Hernandez M.J.; Munoz M.A.; Rodriguez-Pichardo A.; Camacho F.

Significance of psychosomatic factors in etiopathogenesis of alopecia areata
pp. 126-127(2)
Authors: Blagojevic D.; Martinovic N.

Pro-inflammatory cytokine cascade in human plucked hair
pp. 127-127(1)
Authors: Mahe Y.F.; Buan B.; Billoni N.; Loussouarn G.; Michelet J.-F.; Gautier B.; Bernard B.A.

The liver monoxygenase system in patients with alopecia
pp. 127-127(1)
Authors: Arifov S.; Adilov M.; Mamatkulov U.; Abidova Z.; Mavljanova S.

Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism
pp. 127-127(1)
Authors: Yucelten A.D.; Gurbuz O.; Erenus M.; Durmusoglu F.; Ulug U.

The ideal catagen of the hair
pp. 127-128(2)
Author: Marliani A.

Microscopic study of a hair at the level of the sub-infundibulum in polarized light
pp. 128-128(1)
Authors: Marliani A.; Salin M.

Nail pathology illustrated on CD-ROM
pp. 128-128(1)
Authors: Haneke E.; Andre J.; Arnouts T.

Tinea capitis of kerion Celsi type caused by Microsporum canis - Coincidence or unusual clinical variation in Croatia?
pp. 128-128(1)
Authors: Skerlev M.; Cerjak N.; Murat-Susic S.; Husar K.

South American blastomycosis with intestinal lymphangiectasia
pp. 129-129(1)
Authors: Souza I.S.; Nazareth R.F.; Santana L.C.; Silva R.C.

Tuberculosis verrucosa cutis, erythema induratum and P.C.R.
pp. 129-129(1)
Authors: Diaz C.; Cucurell M.; Jeremias J.; Barranco C.; Carrato C.; Escribano G.; Camarasa J.

Phagocytosis and oxydative burst of neutrophils in patients with recurrent furunculosis
pp. 129-129(1)
Authors: Demircay Z.; Demiralp E.; Ergun T.; Kibaroglu A.; Akoglu T.

A prospective survey of tinea capitis in 10.000 schoolchildren and household members in Madrid
pp. 129-129(1)
Authors: Cuetara M.S.; del Palacio A.; Pereiro M.; Noriega A.R.

Cutaneous onchocerciasis in republic of Yemen (10 cases reported)
pp. 130-130(1)
Author: Almoallimi M.A.-Q.

Myiasis in Republic of Yemen (Cutaneous myiasis pubis one case reported and genito-urinary myiasis two cases reported)
pp. 130-130(1)
Author: Almoallimi M.A.-Q.

Toxocara infection and cutaneous diseases. A case-control study
pp. 130-130(1)
Authors: Humbert P.; Niezborala M.; Salembier R.; Aubin F.; Barale T.; Buchet S.; Tessier-Cotte C.

Trigeminal trophic syndrome
pp. 130-131(2)
Authors: Murphy M.; Barnes L.

Life threatening dermatoses in derma tological department of university of medicine from Cluj (Romania)
pp. 131-131(1)
Author: Tataru A.D.

Skin manifestations of patients with liver cirrhosis
pp. 131-131(1)
Authors: Chang S.H.; Lee H.T.; Yoon T.Y.

Cell motility and hypoxia dramatically increase the secretion of IL-8 by human keratinocytes
pp. 131-131(1)
Authors: O'Toole E.A.; Khanna V.J.; Kondo S.; Sauder D.N.; Woodley D.T.

Necrobiosis lipoidica - Its association with diabetes mellitus
pp. 131-132(2)
Authors: O'Toole E.A.; Campbell R.; Rogers S.; Young M.M.; Barnes L.

The spectrum of intra-areolar accessory mammary tissue
pp. 132-132(1)
Authors: Urbani C.E.; Betti R.

Beneficial effect of cimetidine in severe aphtosisis related to shift in lymphocyte subpopulations
pp. 132-132(1)
Authors: Glinski W.; Gorska R.; Dwilewicz-Trojaczek J.

A CD-rom based program for clinical dermatology: Applications
pp. 132-132(1)
Authors: Landthaler M.; Stolz W.; Arnouts T.; Braun-Falco O.

Efficacy, tolerability and optimal dose of fexofenadine in chronic idiopathic urticaria
pp. 132-133(2)
Authors: European Fexofenadine Investigators Group; Pywell J.M.; Berth-Jones J.; Stern M.

Diffuse cutaneous mastocytosis spontaneously regressing in an adult
pp. 133-133(1)
Authors: Petrescu Z.; Dobrescu A.; Dobrescu G.; Florea N.; Taranu T.; Solovatistru L.; Tutuianu I.; Theodoru R.; Stoica L.; Petrescu B.C.; Stoleriu G.; Dobre C.

A survey on tolerability in a cohort of 854 patients receiving peroral antifungals
pp. 133-133(1)
Authors: Heikkila H.; Mynttinen S.; Nuutinen M.; Porki I.; Stubb S.

Eosinophil populations in patients with atopic dermatitis and opisthorchiasis
pp. 133-133(1)
Authors: Popova S.D.; Toropova N.P.

Lichen erosivus vulvae treatment with acitretin
pp. 133-133(1)
Authors: Isailovic G.; Presetnik L.; Veljkovic M.; Bjekic M.

75-TH anniversary of the polish association of dermatology
pp. 134-134(1)
Authors: Gorkiewicz-Petkow A.; Glinski W.

Derminform: Trends in online - and teledermatology in Germany
pp. 134-134(1)
Authors: Herbst W.M.; Otto M.; Bohm K.; Dingeldein D.

Mondor's disease. Report of four cases
pp. 134-134(1)
Authors: Mayor M.; Lazaro T.; Buron I.; Herranz P.; de Mora J.C.; Casado M.

Impaired fibrin-cuffs dissolution by urokinase in chronic venous leg ulcers
pp. 134-135(2)
Authors: Vannucchi P.L.; Cagnoni M.L.; Polignano R.; Lotti T.

Armauer Hansen (1841-1912): The life of the discoverer of the aetiology of leprosy
pp. 135-135(1)
Author: Nyfors A.

Subcorneal pustular dermatosis
pp. 135-135(1)
Authors: Gore H.E.; Black R.J.; Eedy D.J.; McCusker G.

Lichenoid tattoo reaction
pp. 135-135(1)
Authors: Gore H.E.; Eedy D.J.; Somerville J.

Endoscopic dorsal sympathectomy the treatment for hyperhidrosis
pp. 135-135(1)
Authors: Rat P.; Bernard A.; Dalac S.; Favre J.P.; Lambert D.

Herpes zoster in children
pp. 136-136(1)
Authors: Kakourou T.; Theodoridou M.; Mostrou G.; Syriopoulou V.; Papadogeorgaki H.; Constantopoulos A.

Gianotti-crosti syndrome. A comparative study between 1976-84 and 1992-95 in Spain
pp. 136-136(1)
Authors: Fonseca E.; del Pozo J.; Zapico R.

Follow-up study or pre-pubertal children with ano-genital warts
pp. 136-136(1)
Authors: Armstrong D.K.B.; Bingham E.A.; Dinsmore W.W.; Swann A.; Handley J.M.

Cutaneous leishmaniasis presenting as child abuse
pp. 136-136(1)
Authors: Haynes T.; Miner J.; El-Hoshi K.; Iacobelli D.; Hashimoto K.

Purpura fulminans in newborn child with protein C deficiency
pp. 137-137(1)
Author: Okrasinski H.

A girl with both piebaldism and neurofibromatosis type I
pp. 137-137(1)
Authors: Angelo C.; Grosso M.G.; Zambruno G.; Cianchini G.; Cacciaguerra M.G.; Puddu P.; Paradisi M.

Ehlers-Danlos syndrome type IV: Relevance of cutaneous examination
pp. 137-137(1)
Authors: Gimenez-Arnau A.; Sales-Moreno P.; Pla-Ferrer C.; Barranco C.; Lloreta-Trull J.; Nolla-Salas J.; Camarasa J.G.

Striate palmoplantar keratoderma: Evidence of genetic heterogeneity
pp. 137-137(1)
Authors: Armstrong D.K.B.; McGibbon D.; McKenna K.E.; Hughes A.E.

Langerhans' cells histiocytosis
pp. 137-138(2)
Authors: Cestari T.; Casagrande M.; Weissbluth M.; Daudt L.; Bakos L.

Cyclosporin in childhood atopic dermatitis
pp. 138-138(1)
Authors: Ahmed I.; Berth-Jones J.

Tuberous sclerosis: A clinical and genetic study
pp. 138-138(1)
Authors: Bonvicino A.; Grosso E.; Carbonara C.; Bundino S.; Migone N.; Pippione M.

Particular clinical aspects in infantile psoriasis
pp. 138-138(1)
Authors: Petrescu Z.; Taranu T.; Solovastru L.; Branisteanu D.; Tutuianu I.; Dobre C.

The prevalence of eczema and contact allergy in 8th grade school children
pp. 139-139(1)
Authors: Mortz C.G.; Bindslev-Jensen C.; Lauritsen J.; Andersen K.E.

Microsatellite alterations in type 1 neurofibromatosis-NF1-
pp. 139-139(1)
Authors: Richetta A.; Giustini S.; Amorosi B.; Canci C.; Silipo V.; Occhini L.; Mariani Costantini R.; Calvieri S.

Ultrastructural changes after long-term PUVA-therapy
pp. 139-139(1)
Authors: Placek W.J.; Jasiel-Walikowska E.; Wrzolek T.

A genetic study in erythropoietic protoporphyria
pp. 139-139(1)
Authors: Horkay I.; Remenyik E.; Moore M.R.; Lanyon G.W.

In vivo detection of basal cell carcinoma with imaging spectroscopy
pp. 140-140(1)
Authors: Wennberg A.-M.; Larko O.; Molne L.; Gudmundson F.; Rosen A.

Ultra violet instrument system interfaced to a personal computer
pp. 140-140(1)
Authors: Clarkson D.M.; Ilchyshyn A.

Evaluation of ultraviolet-B susceptibility in the population of Rio Grande do Sul, Brazil
pp. 140-140(1)
Authors: Cestari T.F.; Miozzo A.; Brodt C.; Pacheco F.; Bakos L.

Interest of a computerized digital imaging system in the follow-up of pigmented lesions
pp. 140-140(1)
Authors: Amaro J.A.; Sampaio R.C.

Malignant melanoma: A case 14 years later
pp. 140-141(2)
Authors: Rodriguez C.; Trillo M.; Brana X.C.

Dysplastic naevi and risk for melanoma: 1997 patient care guidelines in The Netherlands
pp. 141-141(1)
Authors: van Voorst Vader P.C.; Bergman W.; Ruiter D.J.

Role of copper in the pathogenesis of vitiligo
pp. 141-141(1)
Authors: Vaisov A.; Arifov S.; Rahmatov A.; Alimhanov K.; Hasanov J.

The incidence of aggressive-growth basal cell carcinoma in young adults: A retrospective study on 964 patients
pp. 141-141(1)
Authors: Garcovich A.; Catamo F.; Zampetti A.; Olivetti G.; Larocca L.M.; Alotto M.; Corradini C.

Elastic fibres in differentiation of Spitz nevus from malignant melanoma
pp. 141-141(1)
Authors: Pizinger K.; Cetkovska P.

''Photodistributed'' cutaneous T small cell lymphoma with granulomatous reaction
pp. 142-142(1)
Authors: Adamski H.; Chevrant-Breton J.; Le Gall F.; Jego P.; Cartron L.; Weschler J.; Drenou B.; Leblay R.; Sigaux F.

Scintigraphy of melanoma lesions using 99mTc-IL2
pp. 142-142(1)
Authors: Bottoni U.; Signore A.; Innocenzi D.; Latini A.; Richetta A.; Silipo V.; Barone R.; Calvieri S.

Pyoderma gangrenosum-like lesions in a patient with acute myeloid leukemia
pp. 142-142(1)
Authors: Pranteda G.; Gueli N.; Innocenzi D.; De Simone P.; Clerico R.; Bottoni U.; Calvieri S.

Microsatellite instability in primary and metastatic melanoma
pp. 142-142(1)
Authors: Richetta A.; Silipo V.; Bottoni U.; Innocenzi D.; Latini A.; Calvieri S.

Tumors of vascular tissue in the Republic of Yemen: 4 case reports
pp. 142-143(2)
Author: Almoallimi M.A.-Q.

Positron emission tomographie in melanoma staging
pp. 143-143(1)
Authors: Frohmann J.P.; Mulkens P.J.M.; Prieur H.; Bender H.; Reinhold U.

Cutaneous clinical presentation of chronic myelogenous leukemia
pp. 143-143(1)
Authors: Cattonar P.; Pozzato G.; Pussini E.; Canelles M.F.; Grandi G.; Trevisan G.

Eruptive kerato-acanthoma (EKA)